microRNA-10b

Hansa Biopharma Reports Positive Idefirix Results

LUND, Sweden, May 27, 2026 Hansa Biopharma AB has announced positive topline results from its European Post Authorization Efficacy...

By cGxPwire Editor
May 28, 2026

.Clinical

TransCode Starts Phase 2a Trial for TTX-MC138

BOSTON, May 27, 2026 TransCode Therapeutics, Inc., a clinical-stage biotechnology company focused on RNA-based cancer therapeutics, has announced the...

By cGxPwire Editor
May 28, 2026

.Clinical Bio-Pharma

TransCode Reports Positive Phase 1a Results for TTX-MC138 in Metastatic Cancer

BOSTON, Massachusetts, October 14, 2025 — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) today announced encouraging preliminary data from its completed...